What To Expect From AVITA Medical Inc (RCEL) Q3 2025 Earnings

This article first appeared on GuruFocus.

AVITA Medical Inc (NASDAQ:RCEL) is set to release its Q3 2025 earnings on Nov 6, 2025. The consensus estimate for Q3 2025 revenue is $18.18 million, and the earnings are expected to come in at -$0.28 per share. The full year 2025's revenue is expected to be $75.56 million and the earnings are expected to be -$1.25 per share. More detailed estimate data can be found on the Forecast page.

Warning! GuruFocus has detected 4 Warning Signs with RCEL.

Is RCEL fairly valued? Test your thesis with our free DCF calculator.

Revenue estimates for AVITA Medical Inc (NASDAQ:RCEL) have declined from $99.00 million to $75.57 million for the full year 2025 and from $135.32 million to $100.83 million for 2026 over the past 90 days. Earnings estimates have declined from -$0.68 per share to -$1.25 per share for 2025 and from -$0.17 per share to -$0.71 per share for 2026 over the same period.

In the previous quarter of 2025-06-30, AVITA Medical Inc's (NASDAQ:RCEL) actual revenue was $18.42 million, which missed analysts' revenue expectations of $22.61 million by -18.54%. AVITA Medical Inc's (NASDAQ:RCEL) actual earnings were -$0.38 per share, which missed analysts' earnings expectations of -$0.25 per share by -53.23%. After releasing the results, AVITA Medical Inc (NASDAQ:RCEL) was down by -21% in one day.

Based on the one-year price targets offered by 5 analysts, the average target price for AVITA Medical Inc (NASDAQ:RCEL) is $7.50 with a high estimate of $14.00 and a low estimate of $3.00. The average target implies an upside of 107.76% from the current price of $3.61.

Based on GuruFocus estimates, the estimated GF Value for AVITA Medical Inc (NASDAQ:RCEL) in one year is $20.05, suggesting an upside of 455.40% from the current price of $3.61.

Based on the consensus recommendation from 6 brokerage firms, AVITA Medical Inc's (NASDAQ:RCEL) average brokerage recommendation is currently 2.5, indicating an \\"Outperform\\" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.

Scroll to Top